Editorial Opinion: "Patented and BAT-licensed altered nicotine technology that will disrupt a $700B Worldwide Tobacco Industry with 5 different revenue streams on both the consumer product and pharmaceutical side of smoking cessation and modified risk tobacco products - $1B+ mkt cap potential"
22nd Century Group to Acquire Participating Member of the Tobacco Master Settlement Agreement (MSA) - Sept 18, 2013
22nd Century Subsidiary Goodrich Tobacco Company Granted Federal Permit to Manufacture Tobacco Products - Mar. 10, 2014 22nd Century Group Eliminates $7.7 Million of Warrant Liability - Apr. 1, 2014 22nd Century Group Files $45M Shelf Registration and Provides Business Update - Apr. 21, 2014 22nd Century Group Signs Letter of Intent w/ European Factory for Production of Nicotine-Free Cigarettes in Europe - May 29, 2014 22nd Century Group Engages CRO for FDA Regulatory Activities for Company's Modified Risk Cigarettes - Jul 11, 2014 Patents Granted for 22nd Century Group's Technology to Virtually Eliminate Nicotine in Tobacco Plants - Jul 30, 2014 XXII Current Stock Chart: